Search filters

List of works by Jaap J M Teunissen

Comparison of [(177)Lu-DOTA(0),Tyr(3)]octreotate and [(177)Lu-DOTA(0),Tyr(3)]octreotide: which peptide is preferable for PRRT?

scientific article published on 18 July 2006

Comparison of response evaluation in patients with gastroenteropancreatic and thoracic neuroendocrine tumors after treatment with [177Lu-DOTA0,Tyr3]octreotate

scientific article published in October 2013

Endocrine tumours of the gastrointestinal tract. Peptide receptor radionuclide therapy

scientific article

Hypocalcaemia after treatment with [177Lu-DOTA 0,Tyr3]octreotate

scientific article published on 23 July 2013

Improved Control of Severe Hypoglycemia in Patients with Malignant Insulinomas by Peptide Receptor Radionuclide Therapy ⬇️

scientific article published on September 14, 2011

Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors.

scientific article

Lutetium-labelled peptides for therapy of neuroendocrine tumours ⬇️

scientific article published on February 1, 2012

Molecular radiotherapy with somatostatin analogs for (neuro-)endocrine tumors.

scientific article

Neoadjuvant Treatment of Nonfunctioning Pancreatic Neuroendocrine Tumors with [177Lu-DOTA0,Tyr3]Octreotate

scientific article published on 13 August 2015

Nephrotoxicity after PRRT with (177)Lu-DOTA-octreotate

scientific article published on 10 May 2016

Neuroendocrine Tumors

Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours

scientific article published on 17 October 2011

Peptide receptor radionuclide therapy (PRRT) for GEP-NETs

scientific article published in December 2012

Preclinical and clinical studies of peptide receptor radionuclide therapy

scientific article published on May 2010

Quality of Life in 265 Patients with Gastroenteropancreatic or Bronchial Neuroendocrine Tumors Treated with [177Lu-DOTA0,Tyr3]Octreotate ⬇️

scientific article published on July 27, 2011

Quality of life in patients with gastroenteropancreatic tumors treated with [177Lu-DOTA0,Tyr3]octreotate

scientific article

Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors

scientific article

Salvage peptide receptor radionuclide therapy with [177Lu-DOTA,Tyr3]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours

scientific article published on 28 September 2018

Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors

scientific article published on 29 January 2010

Staging and treatment of differentiated thyroid carcinoma with radiolabeled somatostatin analogs

scientific article

Subacute haematotoxicity after PRRT with (177)Lu-DOTA-octreotate: prognostic factors, incidence and course

scientific article published on 30 September 2015

Therapy-related hematological malignancies after peptide receptor radionuclide therapy with (177)Lu-DOTA-Octreotate: Incidence, course & predicting factors in patients with GEP-NETs

scientific article published on 03 August 2017

Treatment of Gastroenteropancreatic Neuroendocrine Tumors with Peptide Receptor Radionuclide Therapy ⬇️

scientific article published on January 10, 2012

Treatment of patients who have endocrine gastroenteropancreatic tumors with radiolabeled somatostatin analogues

scientific article published on June 2007

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA(0),Tyr3]octreotate

scientific article

Tumor Response Assessment to Treatment with [177Lu-DOTA0,Tyr3]Octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors: Differential Response of Bone Versus Soft-Tissue Lesions ⬇️

scientific article published on July 10, 2012

Paulina is supported by:

About Paulina

Help